Brain Cancer

Short-course hypofractionated proton beam therapy incorporating advanced imaging may improve overall survival over standard radiation therapy in people over 65 with grade 4 malignant glioblastoma.

Mayo Clinic Comprehensive Cancer Center researchers spent 2024 mining patient data, leveraging artificial intelligence and conducting clinical trials to reveal insights that improve patient care.

Dr. Rich Byrne, a Mayo Clinic neurosurgeon, explains how brain tumors are classified and what that means for treatment.

Findings show extended progression-free survival for people with meningiomas who received a radiopharmaceutical approved for neuroendocrine tumors.

Mayo Clinic study findings reveal a protein that increases glioblastoma malignancy, a new understanding of the tumor's biology, and a potential new treatment strategy.

Dr. Alfredo Quiñones-Hinojosa, a Mayo Clinic neurosurgeon, discusses brain tumors and how they are diagnosed and treated.

Study results show a new surgical platform enables real-time diagnoses and tailored surgical treatment in the operating room.

Dr. Alfredo Quinones-Hinojosa discusses glioblastoma, a type of aggressive brain tumor, and the role of research in advancing treatment.

Dr. Jonathan Schwartz discusses medulloblastoma treatment for children, the latest advances, and what families should look for in a care team.

Drs. Terry Burns and Alfredo Quiñones-Hinojosa discuss brain tumors called gliomas and the hope being offered by new technology and clinical trials.